Showing results (1111-1120 of 3,171) with videos related to
Sort By:
Pageof 318
Inflammatory Bowel Diseases|May 25, 2013
Incidence, presentation, and prognosis of small bowel adenocarcinoma in patients with small bowel Crohn's disease: a prospective observational studyKhaldoun Elriz, Fabrice Carrat, Franck Carbonnel, et al.Photochemistry and Photobiology|September 4, 2015
Protective Effect of Dermal Brimonidine Applications Against UV Radiation-induced Skin Tumors, Epidermal Hyperplasia and Cell Proliferation in the Skin of Hairless MiceGuy Bouvier, Douglas B Learn, Christelle Nonne, et al.Annales De Biologie Clinique|November 25, 2020
[Remethylation disorders: about two cases]Marina Brailova, Damien Bouvier, Adeline Regnier, et al.Molecular Pharmacology|April 12, 2008
Conformational rearrangements and signaling cascades involved in ligand-biased mitogen-activated protein kinase signaling through the beta1-adrenergic receptorSégolène Galandrin, Geneviève Oligny-Longpré, Hélène Bonin, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 9, 2014
Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: a French population-based studyFrancois Ghiringhelli, Audrey Hennequin, Antoine Drouillard, et al.Environmental Microbiology|December 17, 2009
Seasonal variations of phage life strategies and bacterial physiological states in three northern temperate lakesC F Maurice, T Bouvier, J Comte, et al.Nucleic Acids Research|June 25, 2024
Aptamer binding footprints discriminate α-synuclein fibrillar polymorphs from different synucleinopathiesAlix Bouvier-Müller, Deborah Fourmy, Alexis Fenyi, et al.Protein Expression and Purification|September 26, 2001
Increased production of active human beta(2)-adrenergic/G(alphas) fusion receptor in Sf-9 cells using nutrient limiting conditionsE Carpentier, D Lebesgue, A A Kamen, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 23, 2026
In vitro activity of β-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with aztreonam against metallo-β-lactamase producing Escherichia coli clinical isolatesClément Viguier, Samanta Freire, Maxime Bouvier, et al.Bioorganic & Medicinal Chemistry Letters|November 9, 2017
Phenoxypropanolamine derivatives as selective inhibitors of the 20S proteasome β1 and β5 subunitsAnna A Hovhannisyan, The Hien Pham, Dominique Bouvier, et al.Pageof 318